Cibc Private Wealth Group, LLC Alnylam Pharmaceuticals, Inc. Transaction History

Cibc Private Wealth Group, LLC

$51.3 Billion
Q1 2025

A detailed history of Cibc Private Wealth Group, LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 205,511 shares of ALNY stock, worth $87 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

205,511

Previous 203,368 1.05%

Holding current value

$87 Million

Previous $47.9 Million 15.96%

% of portfolio

0.11%

Previous 0.09%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$233.07 - $290.7 $499,469 - $622,970	2,143 Added 1.05%	205,511 $55.5 Million
Q4 2024 Feb 12, 2025	SELL	$232.27 - $300.43 $1.19 Million - $1.54 Million	-5,118 Reduced 2.45%	203,368 $47.9 Million
Q3 2024 Nov 13, 2024	BUY	$233.81 - $287.01 $489,831 - $601,285	2,095 Added 1.02%	208,486 $57.4 Million
Q2 2024 Aug 09, 2024	BUY	$143.31 - $247.0 $4.61 Million - $7.94 Million	32,142 Added 18.45%	206,391 $50.2 Million
Q1 2024 May 10, 2024	BUY	$146.51 - $198.2 $80,287 - $108,613	548 Added 0.32%	174,249 $26 Million
Q4 2023 Feb 13, 2024	SELL	$151.41 - $196.57 $64,954 - $84,328	-429 Reduced 0.25%	173,701 $33.2 Million
Q3 2023 Nov 13, 2023	SELL	$170.77 - $211.65 $65,234 - $80,850	-382 Reduced 0.22%	174,130 $30.8 Million
Q2 2023 Nov 21, 2023	BUY	$185.01 - $212.05 $70,673 - $81,003	382 Added 0.22%	174,512 $33.1 Million
Q2 2023 Aug 10, 2023	BUY	$185.01 - $212.05 $9.9 Million - $11.4 Million	53,531 Added 44.25%	174,512 $33.1 Million
Q1 2023 Nov 21, 2023	SELL	$182.66 - $235.53 $9.71 Million - $12.5 Million	-53,149 Reduced 30.52%	120,981 $24.2 Million
Q1 2023 May 11, 2023	SELL	$182.66 - $235.53 $161,654 - $208,444	-885 Reduced 0.73%	120,981 $24.2 Million
Q4 2022 Jun 01, 2023	BUY	$185.53 - $241.31 $164,194 - $213,559	885 Added 0.73%	121,866 $29 Million
Q4 2022 Feb 13, 2023	BUY	$185.53 - $241.31 $456,032 - $593,139	2,458 Added 2.06%	121,866 $29 Million
Q3 2022 Nov 14, 2022	BUY	$138.54 - $232.0 $438,617 - $734,512	3,166 Added 2.72%	119,408 $23.9 Million
Q2 2022 Aug 03, 2022	SELL	$120.42 - $169.29 $485,894 - $683,085	-4,035 Reduced 3.35%	116,242 $17 Million
Q1 2022 May 16, 2022	BUY	$127.18 - $173.91 $257,539 - $352,167	2,025 Added 1.71%	120,277 $19.6 Million
Q4 2021 Feb 08, 2022	SELL	$159.56 - $209.29 $142,487 - $186,895	-893 Reduced 0.75%	118,252 $20.1 Million
Q3 2021 Nov 12, 2021	BUY	$169.75 - $207.73 $72,822 - $89,116	429 Added 0.36%	119,145 $22.5 Million
Q2 2021 Aug 16, 2021	SELL	$128.63 - $176.89 $970,384 - $1.33 Million	-7,544 Reduced 5.97%	118,716 $20.1 Million
Q1 2021 May 12, 2021	BUY	$126.83 - $175.69 $16 Million - $22.2 Million	126,260 New	126,260 $17.8 Million
Q2 2018 Aug 02, 2018	SELL	$88.31 - $107.8 $441 - $539	-5 Closed	0 $0
Q1 2018 May 17, 2018	SELL	$115.92 - $148.54 $875,196 - $1.12 Million	-7,550 Reduced 99.93%	5 $1,000
Q4 2017 Feb 12, 2018	BUY	$114.49 - $139.98 $864,971 - $1.06 Million	7,555	7,555 $960,000

Others Institutions Holding ALNY

# of Institutions

817

Shares Held

115M

Call Options Held

584K

Put Options Held

648K

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $52.1B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Private Wealth Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Private Wealth Group, LLC with notifications on news.

Account

Cibc Private Wealth Group, LLC Alnylam Pharmaceuticals, Inc. Transaction History